Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Neelima Chintapalli

Hematology Oncology | Hematology | Oncology
Christus Trinity Clinic
1453 E Bert Kouns Industrial Loop, Cancer Treatment Center, 
Shreveport, LA 
Accepting New Patients
Experienced in WT1-Related Wilms Tumor Syndromes
Christus Trinity Clinic
1453 E Bert Kouns Industrial Loop, Cancer Treatment Center, 
Shreveport, LA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Neelima Chintapalli is a Hematologist Oncology specialist and a Hematologist in Shreveport, Louisiana. Dr. Chintapalli is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Pleuropulmonary Blastoma, Angiosarcoma, Breast Cancer, Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Chintapalli is currently accepting new patients.

Her clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in LA
Hospital Affiliations
Christus Shreveport-Bossier Health System
Christus St Frances Cabrini Hospital
Willis Knighton Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

CHRISTUS TRINITY CLINIC
1453 E Bert Kouns Industrial Loop, Cancer Treatment Center, Shreveport, LA 71105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III Randomized Double-blind, Placebo Controlled Study of Alpelisib in Combination With Fulvestrant for Men and Postmenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment
A Phase III Randomized Double-blind, Placebo Controlled Study of Alpelisib in Combination With Fulvestrant for Men and Postmenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment
Enrollment Status: Completed
Publish Date: February 13, 2025
Intervention Type: Drug
Study Drugs: Fulvestrant, Alpelisib
Study Phase: Phase 3
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2024
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure
LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug, Device
Study Drug: Immune checkpoint inhibitors or docetaxel
Study Phase: Phase 3
View 2 Less Clinical Trials
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Anil Veluvolu
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Anil Veluvolu
Hematology Oncology | Hematology | Oncology

Wk Hematology Oncology Associates

2600 Kings Hwy, Suite 340, 
Shreveport, LA 
 (5.3 miles away)
318-212-8620
Languages Spoken:
English
See accepted insurances

Anil Veluvolu is a Hematologist Oncology specialist and a Hematologist in Shreveport, Louisiana. Dr. Veluvolu is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Colorectal Cancer, Lynch Syndrome, and Liver Embolization.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Tyler D. Lash
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Tyler D. Lash
Hematology Oncology | Hematology | Oncology

Wk Hematology Oncology Associates

2600 Kings Hwy, Suite 340, 
Shreveport, LA 
 (5.3 miles away)
318-212-8620
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Tyler Lash is a Hematologist Oncology specialist and a Hematologist in Shreveport, Louisiana. Dr. Lash is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Small Cell Lung Cancer (SCLC), Monoclonal Gammopathy of Undetermined Significance (MGUS), Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Lash is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Manish Dhawan
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Manish Dhawan
Hematology Oncology | Hematology | Oncology

Mary Bird Perkins Cancer Center

850 Olive St, Suite A, 
Shreveport, LA 
 (5.0 miles away)
318-239-4860
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Manish Dhawan is a Hematologist Oncology specialist and a Hematologist in Shreveport, Louisiana. Dr. Dhawan is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Pancreatic Cancer, Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Endoscopy, and Colonoscopy. Dr. Dhawan is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chintapalli's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 30 Advanced Conditions
    View All 132 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile